Study Links Vaping to Irregular Heartbeats in Mice

Nov.03.2022
Study Links Vaping to Irregular Heartbeats in Mice
A study on e-cigarette liquids causing heart rhythm disruption in mice is criticized for its lack of relevance to humans.

A newspaper has reported on a study claiming that electronic cigarette liquid can disrupt heart rhythms, but has failed to highlight that the study was conducted on mice and involved toxic doses. An expert on tobacco reduction has pointed out that the only information this study provides is that "pet mouse owners should not allow their mice to use electronic cigarettes.


According to The Independent, a new study has found that using e-cigarette fluids containing certain ingredients can cause heart rhythm irregularities, thereby increasing the risk of heart attacks.


A recent study published in Nature Communications suggests that e-cigarettes and their individual components can cause irregular heart rhythms and conduction defects in mice. The researchers conducted electrocardiogram tests on mice after acute inhalation of e-cigarette vapors. They argue that "our findings suggest that the chemical composition of e-cigarettes may increase cardiac risk by inducing changes that promote arrhythmogenesis and stimulate autonomic reflexes.


Experts in tobacco harm reduction and e-cigarettes quickly criticized the study. Professor Jacob George, Head of Cardiovascular Medicine and Therapeutics at the University of Dundee Medical School, said: "The metabolism of mice is very different from that of humans, and to be honest, any inference to long-term human health effects are at best speculative. If this were indeed true, given the large number of e-cigarette users worldwide, we would have expected to see a dramatic increase in cases of arrhythmia, which we have not seen in clinical practice.


The controversial nature of e-cigarettes brings into question the preliminary and speculative science surrounding its potential impact on human health, including the effects of nicotine on blood vessels. However, large-scale observational studies of users of nicotine replacement therapy have shown no increase in heart events. These findings should not deter those seeking to quit smoking from attempting e-cigarettes or nicotine replacement therapy. This early-stage preclinical research requires further clinical work before it can be considered directly related to human health.


Professor Peter Hajek, director of the Tobacco Dependence Research Department at Queen Mary University of London, added that "in this study, mice were exposed to aerosols from e-cigarette solvents with and without nicotine, as well as acrolein (a chemical that may be produced due to overheating) in e-cigarette liquid. Such exposure was associated with short-term changes in the mice's electrocardiograms and an increase in heart rate.


When talking about applying the results of this study to humans, there are several issues to consider. Electronic cigarette users are unlikely to be exposed to significant levels of acrolein since overheated e-liquid produces an unpleasant taste that people tend to avoid. While the study used exposure levels to other chemicals that humans can tolerate, the same dose may cause significant pain in much smaller mammals with more sensitive olfactory systems and varying tolerances to medication. It would be strange if animals exposed to aversive stimuli did not show a cardiovascular response. The reason for using mice in this study remains unclear. When experiments cannot be conducted on humans, animal models may be used, but comparing heart rate and electrocardiograms for electronic cigarette components and human smoking reactions is not without hurdles.


Professor Kevin McConway, Honorary Professor of Applied Statistics at The Open University in the UK, continues to criticize and has released a detailed statement saying: "As a statistician and not a biologist, I am unable to comment on the physiological details of this study. However, in my view, most aspects of the statistical analysis of the experimental results are reliable, and the study provides good evidence that certain components of e-cigarettes do indeed affect some aspects of mouse heart function when the mice are exposed to these components in the way done in this study. Nevertheless, while I believe that investigating the potential harmful effects of e-cigarette components is certainly worthwhile, and I also believe that animal experiments can play a role in this work, this work cannot answer some important questions.


I don't believe any knowledgeable commentator has suggested that using e-cigarettes is without risk. The important question is how the harm of using e-cigarettes compares to the harm that would result if the person did not use them. This, of course, depends on what the person would do if they did not use e-cigarettes. If they are a traditional smoker and e-cigarettes help them quit, then using e-cigarettes would prevent greater harm from their previous smoking habit. Other studies have shown that e-cigarettes can effectively help people quit smoking and are often more effective than nicotine replacement therapy like patches or gum. So, when used by smokers, the real question is not whether e-cigarettes are completely harmless, but whether they are safer than continuing to smoke or using other methods to quit, which may be less effective. This new study does not shed light on that question, and there is no evidence in its findings to suggest that using e-cigarettes is as harmful as smoking regular cigarettes, even in mice.


For those who are not yet smokers, electronic cigarette companies say it may be different. However, people still need to consider whether using electronic cigarettes may lead to other dangerous habits, such as using different drugs.


To the best of my understanding, this study has the potential to distinguish the effects of different components in e-cigarettes to some extent, which is an advantage. For example, this could lead to the development of safer e-cigarettes. However, as noted by the researchers, the reactions to various chemicals observed in mice may not necessarily apply to humans, even though this study specifically looks at several components of e-cigarettes and their potential effects on mice. Therefore, there is still a lot of work to be done and all relevant factors must be taken into consideration.


In addition, the study used a very small number of female mice - only four - and these mice did not come into contact with most of the substances involved. This means that, as the researchers have themselves acknowledged, some of the potential conclusions about gender differences are not based on evidence. Finally, these mice were (of course) completely unfamiliar with e-cigarettes, and the researchers note that the effects may be very different for individuals who have experience with e-cigarettes or tobacco use.


Dr. Adam Jacobs, Senior Director of Biostatistics at Premier Research, provided commentary on the study, stating "This study suggests that mice exposed to e-cigarette aerosol in a closed space for 90 minutes experience short-term changes in heart rhythm. While the long-term effects of these changes are not yet clear, it seems prudent for pet owners to avoid exposing their rodents to e-cigarettes. For humans, while e-cigarettes cannot be considered completely safe, there is a significant amount of evidence showing it to be much safer than smoking combustible cigarettes. Therefore, smokers who switch from traditional cigarettes to e-cigarettes will greatly reduce their health risks.


Statement:


The content of this article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the translator's skills, the translated article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS remains completely aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer
2Firsts Talks with Nancy Loucas, Asia-Pacific THR Leader: Giving a Voice to the Overlooked Consumer
Ahead of the upcoming Global Forum on Nicotine (GFN), 2Firsts interviews Nancy Loucas, Executive Coordinator of CAPHRA, on why consumers must have a voice in tobacco harm reduction policymaking—and how she’s helping them speak up.
Jun.18
Taking Flight: How Kardinal Builds a Global Vape Brand from Southeast Asia
Taking Flight: How Kardinal Builds a Global Vape Brand from Southeast Asia
Founded in Malaysia, Kardinal quickly rose to global prominence with its user-focused design and high-quality products. Flagship devices like Quik 6000 and Quikpro have won international acclaim. The brand is now expanding into Southeast Asia, the Middle East, and Latin America, steadily building its global footprint.
Jun.27
2Firsts Insights|JT to Launch New Ploom AURA Heated Device Nationwide in July
2Firsts Insights|JT to Launch New Ploom AURA Heated Device Nationwide in July
Japan Tobacco (JT) has launched a new heated tobacco device, Ploom AURA, along with EVO sticks in three flavors. The device features advanced heating and Bluetooth support. JT plans to invest ¥650 billion in reduced-risk products and aims to capture 10% of Japan’s heated tobacco market by 2028.
May.27 by 2FIRSTS.ai
15 EU Countries Call on Commission to Set Minimum Tax Rates for E-Cigarettes, Nicotine Pouches, and Heated Tobacco
15 EU Countries Call on Commission to Set Minimum Tax Rates for E-Cigarettes, Nicotine Pouches, and Heated Tobacco
Fifteen EU countries have urged the European Commission to revise tobacco tax rules for the first time since 2011. They call for minimum tax rates on e-cigarettes, nicotine pouches, and heated tobacco, and higher taxes on cigarettes and cigars to tackle health risks and illegal trade.
May.27 by 2FIRSTS.ai
World No Tobacco Day 2025: "Unmasking Temptation" Targets Flavors, Marketing, and Design Traps in Nicotine Products
World No Tobacco Day 2025: "Unmasking Temptation" Targets Flavors, Marketing, and Design Traps in Nicotine Products
The theme for World No Tobacco Day 2025 is “Expose the Deception, Protect Life: Unmasking the Alluring Illusions of Tobacco and Nicotine Products.” It directly addresses how the industry uses flavors, packaging, and marketing to create misleading product appeal.
May.06 by 2FIRSTS.ai
Product | Adjustable Flavor Strength and Acidity via Rotating Dial: LOST MARY Launches ULTRASONIC 35K in U.S.
Product | Adjustable Flavor Strength and Acidity via Rotating Dial: LOST MARY Launches ULTRASONIC 35K in U.S.
LOST MARY has released the ULTRASONIC 35K disposable vape in the U.S., offering up to 35,000 puffs. It features a rotating dial to adjust flavor strength and sourness, plus an LED screen showing battery and e-liquid levels. The device is priced at $16.99 and is now available in the U.S.
May.28